{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T17:26:00Z","timestamp":1790270760555,"version":"4.1.0"},"reference-count":23,"publisher":"Elsevier BV","issue":"50","license":[{"start":{"date-parts":[[2012,11,1]],"date-time":"2012-11-01T00:00:00Z","timestamp":1351728000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2012,11]]},"DOI":"10.1016\/j.vaccine.2012.09.075","type":"journal-article","created":{"date-parts":[[2012,10,11]],"date-time":"2012-10-11T14:16:54Z","timestamp":1349965014000},"page":"7260-7264","source":"Crossref","is-referenced-by-count":12,"title":["Rubella seroprevalence in the first birth cohort reaching fertility age after 20 years of two dose universal vaccination policy in Israel"],"prefix":"10.1016","volume":"30","author":[{"given":"Hagai","family":"Levine","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omer E.","family":"Ankol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vladi","family":"Rozhavski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadav","family":"Davidovitch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yair","family":"Aboudy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salman","family":"Zarka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ran D.","family":"Balicer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2012.09.075_bib0005","series-title":"Control of communicable diseases, manual","article-title":"Rubella","author":"Heymann","year":"2008"},{"key":"10.1016\/j.vaccine.2012.09.075_bib0010","doi-asserted-by":"crossref","first-page":"S579","DOI":"10.1093\/infdis\/jir447","article-title":"Global use of Rubella vaccines, 1980\u20132009","volume":"204","author":"Strebel","year":"2011","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2012.09.075_bib0015","series-title":"Vaccines","first-page":"735","article-title":"Rubella vaccine","author":"Plotkin","year":"2008"},{"key":"10.1016\/j.vaccine.2012.09.075_bib0020","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1016\/S1473-3099(08)70282-2","article-title":"Measles, mumps and rubella in Finland: 25 years of a nationwide elimination programme","volume":"8","author":"Peltola","year":"2008","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2012.09.075_bib0025","unstructured":"Eliminating measles and rubella and preventing congenital rubella infection: WHO European Region strategic plan 2005\u20132010. Available at: http:\/\/www.euro.who.int\/__data\/assets\/pdf_file\/0008\/79028\/E87772.pdf [accessed 05.11.11]."},{"issue":"2","key":"10.1016\/j.vaccine.2012.09.075_bib0030","doi-asserted-by":"crossref","first-page":"118","DOI":"10.2471\/BLT.07.042010","article-title":"Comparison of rubella seroepidemiology in 17 countries: progress towards international disease control targets","volume":"86","author":"Nardone","year":"2008","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.vaccine.2012.09.075_bib0035","first-page":"183","article-title":"Control of rubella in Israel: progress and challenge","volume":"24","author":"Slater","year":"1996","journal-title":"Public Health Rev"},{"key":"10.1016\/j.vaccine.2012.09.075_bib0040","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1053\/jinf.2000.0716","article-title":"Clinical rubella reinfection during pregnancy in a previously vaccinated woman","volume":"41","author":"Aboudy","year":"2000","journal-title":"J Infect"},{"key":"10.1016\/j.vaccine.2012.09.075_bib0045","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1016\/j.ypmed.2004.04.036","article-title":"Declining seroprevalence of rubella antibodies among young Israeli adults: a 12-year comparison","volume":"39","author":"Huerta","year":"2004","journal-title":"Prev Med"},{"key":"10.1016\/j.vaccine.2012.09.075_bib0050","first-page":"733","article-title":"Prevalence of antibodies against measles, mumps and rubella in Israeli young adults","volume":"28","author":"Danon","year":"1992","journal-title":"Isr J Med Sci"},{"key":"10.1016\/j.vaccine.2012.09.075_bib0055","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1016\/j.vaccine.2011.01.103","article-title":"Sub-optimal prevalence of mumps antibodies in a population based study of young adults in Israel after 20 years of two dose universal vaccination policy","volume":"29","author":"Levine","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2012.09.075_bib0060","unstructured":"Israel Center for Disease Control and Division of Epidemiology, Public Health Services. Notifiable Infectious Diseases in Israel: 1951\u20132010. Israel Ministry of Health, Publication 342; May 2012. p. 40."},{"key":"10.1016\/j.vaccine.2012.09.075_bib0065","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1016\/j.vaccine.2009.10.130","article-title":"Serum levels of rubella-specific antibodies in Swedish women following three decades of vaccination programmes","volume":"28","author":"Kakoulidou","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2012.09.075_bib0070","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1093\/ajcp\/106.2.170","article-title":"Rubella immunity. Defining the level of protective antibody","volume":"106","author":"Skendzel","year":"1996","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.vaccine.2012.09.075_bib0075","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.vaccine.2011.11.045","article-title":"Seroprevalence of low rubella IgG antibody levels among antenatal women in England tested by NHS blood and transplant: 2004\u20132009. Is rubella susceptibility increasing?","volume":"30","author":"Byrne","year":"2012","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2012.09.075_bib0080","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1017\/S0950268898001071","article-title":"Implementation and evaluation of a measles\/rubella vaccination campaign in a campus university in the UK following an outbreak of rubella","volume":"121","author":"Stevenson","year":"1998","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.vaccine.2012.09.075_bib0085","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/0140-6736(90)90420-A","article-title":"Immunisation and herd immunity","volume":"335","author":"Anderson","year":"1990","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2012.09.075_bib0090","doi-asserted-by":"crossref","first-page":"5604","DOI":"10.1016\/j.vaccine.2006.04.024","article-title":"Use of rubella seroepidemiological data for assessment of previous vaccination policy and for decision making in response to epidemics in Israel","volume":"24","author":"Cohen","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2012.09.075_bib0095","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1086\/528993","article-title":"Persistence of measles, mumps and rubella antibodies in an MMR-vaccinated cohort: a 20-year follow up","volume":"197","author":"Davidkin","year":"2008","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2012.09.075_bib0100","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.vaccine.2007.11.035","article-title":"Incidence of mumps and immunity to measles, mumps and rubella among US military recruits, 2000\u20132004","volume":"26","author":"Eick","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2012.09.075_bib0105","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.4161\/hv.7.12.18111","article-title":"Preventing mumps outbreaks in confined settings: comprehensive ring vaccination as a containment strategy","volume":"7","author":"Levine","year":"2011","journal-title":"Hum Vaccin"},{"key":"10.1016\/j.vaccine.2012.09.075_bib0110","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1016\/j.vaccine.2012.01.044","article-title":"Risk factors of underutilization of childhood immunizations in ultraorthodox Jewish communities in Israel despite high access to health care services","volume":"30","author":"Muhsen","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2012.09.075_bib0115","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1093\/ntr\/nts016","article-title":"Smoking and other correlates of health care services utilization among mandatory military recruits in Israel","volume":"14","author":"Levine","year":"2012","journal-title":"Nicotine Tob Res"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X12014193?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X12014193?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,20]],"date-time":"2018-11-20T01:56:00Z","timestamp":1542678960000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X12014193"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,11]]},"references-count":23,"journal-issue":{"issue":"50","published-print":{"date-parts":[[2012,11]]}},"alternative-id":["S0264410X12014193"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2012.09.075","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2012,11]]}}}